Interpretation of quality-of-life scores
- PMID: 20393476
- PMCID: PMC3150524
- DOI: 10.1038/jid.2010.51
Interpretation of quality-of-life scores
Abstract
Patients' reports of their experience with illness are a key health outcome, but scores that measure these reports can be difficult to interpret. Skindex-29 measures skin-related quality of life reliably and validly. In this issue, Prinsen and colleagues compare patients' responses to "anchor" questions with their Skindex scores to derive clinically meaningful scores for the subscales of Skindex-29. The cutoff scores identify patients whose skin diseases severely affect their quality of life.
Conflict of interest statement
CONFLICT OF INTEREST
The author states no conflict of interest.
Comment in
- 
  
  Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life.J Invest Dermatol. 2011 Sep;131(9):1945-7. doi: 10.1038/jid.2011.138. Epub 2011 May 19. J Invest Dermatol. 2011. PMID: 21593773 No abstract available.
Comment on
- 
  
  Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors.J Invest Dermatol. 2010 May;130(5):1318-22. doi: 10.1038/jid.2009.404. Epub 2009 Dec 24. J Invest Dermatol. 2010. PMID: 20032989
References
- 
    - Bergstresser PR. It’s all about patients. J Invest Dermatol. 2010;130:1–2. - PubMed
 
- 
    - Both H, Essink-Bot ML, Busschbach J, et al. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007;127:2726–39. - PubMed
 
- 
    - Chren MM. Measurement of vital signs for skin diseases. J Invest Dermatol. 2005;125:viii–ix. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
 
        